pyruvic acid has been researched along with levofloxacin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Arnanz, C; de la Campa, AG; Ferrándiz, MJ; Martín-Galiano, AJ; Zimmerman, T | 1 |
Imai, S; Ishibe, K; Itohara, K; Matsubara, K; Nakagawa, S; Nakagawa, T; Osada, Y; Shimazaki, A; Takao, S; Yonezawa, A | 1 |
2 other study(ies) available for pyruvic acid and levofloxacin
Article | Year |
---|---|
Reactive Oxygen Species Contribute to the Bactericidal Effects of the Fluoroquinolone Moxifloxacin in Streptococcus pneumoniae.
Topics: Acetyl-CoA Carboxylase; Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fructosephosphates; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Gene Ontology; Glycolysis; Hydrogen Peroxide; Iron; Levofloxacin; Microbial Sensitivity Tests; Molecular Sequence Annotation; Moxifloxacin; Oxidative Stress; Pyruvate Oxidase; Pyruvic Acid; Streptococcus pneumoniae; Transcription, Genetic | 2016 |
Antibiotic-induced microbiome depletion alters renal glucose metabolism and exacerbates renal injury after ischemia-reperfusion injury in mice.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Blood Glucose; Gastrointestinal Microbiome; Gene Expression Regulation; Glucose; Glucose-6-Phosphatase; Kidney; Levofloxacin; Male; Mice; Mice, Inbred BALB C; Phosphoenolpyruvate Carboxykinase (ATP); Pyruvic Acid; Reperfusion Injury; Vancomycin | 2021 |